ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 274,48
-0,27%
Dow Jones
42 840,26
1,18%
DAX
19 884,75
-0,57%
Brent Oil
72,72
0,00%
Bitcoin
96 559,54
-0,67%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Canadá
  5. TSX

  6. Fennec Pharmaceuticals Inc (FRX) Cours

Fennec Pharmaceuticals Inc

Fennec Pharmaceuticals Inc (FRX)

Flexiroam Limited
8,57
0,11
(1,30%)
Fermé 22 Décembre 10:12PM
Retardé de 15 minutes

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Statistiques et détails clés

Dernier
8,57
Prix Achat
7,00
Prix Vente
8,97
Volume échangé
5 800
8,48 Fourchette du Jour 8,57
5,65 Plage de 52 semaines 15,43
Cap du marché
231,621M
Clôture Veille
8,46
Ouverture
8,48
Dernière Transaction
100
@
8.57
Dernière heure de transaction
Volume financier
-
VWAP
-
Volume moyen (3 m)
2 782
Actions en circulation
27 027 000
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-14,43
Bénéfice par action (BPA)
-0,59
Chiffre d'affairess
21,25M
Bénéfice net
-16,05M

À propos de Fennec Pharmaceuticals Inc

Secteur
Biological Pds,ex Diagnstics
Industrie
Biological Pds,ex Diagnstics
Site Web
www.fennecpharma.com
Siège social
Ottawa, Ontario, Can
Fondé
-
Fennec Pharmaceuticals Inc est coté dans le secteur Biological Pds,ex Diagnstics de la Toronto Stock Exchange avec le ticker FRX. Le dernier cours de clôture d'Fennec Pharmaceuticals était de $8,46. Au cours de la dernière année, les actions de Fennec Pharmaceuticals ont été négociées dans une fourchette de prix de $ 5,65 à $ 15,43.

Fennec Pharmaceuticals compte actuellement 27 027 000 actions en circulation. La capitalisation boursière d'Fennec Pharmaceuticals est de $228,65 million. Fennec Pharmaceuticals a un ratio cours/bénéfice (ratio PE) de -14.43.

FRX Dernières nouvelles

Plus de nouvelles

Fennec Pharmaceuticals Announces Pedmarqsi® Positive Recommendation by NICE for the Prevention of Cisplatin-Induced Hearing Loss in England and Wales

~ PEDMARQSI® (anhydrous sodium thiosulfate) is the first and only treatment available within NHS England and Wales for the prevention of cisplatin-induced ototoxicity (hearing loss) in children...

20 Décembre 2024
GlobeNewswire Inc.

Fennec Pharmaceuticals Announces Early Partial Repayment of Its Outstanding Convertible Debt Facility with Petrichor Healthcare Capital Management

~ $13 Million Convertible Debt Repayment from Available Cash ~ ~ Elimination of Approximately $1.5 Million in Annual Interest Expense and Potential Equity Overhang of Approximately 1.6 Million...

19 Décembre 2024
GlobeNewswire Inc.

Fennec Pharmaceuticals to Participate in Upcoming Investor Conference

RESEARCH TRIANGLE PARK, N.C., Dec. 12, 2024 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that the...

12 Décembre 2024
GlobeNewswire Inc.

Fennec Pharmaceuticals to Participate in Upcoming Investor Conference

RESEARCH TRIANGLE PARK, N.C., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that the...

13 Novembre 2024
GlobeNewswire Inc.

Fennec Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update

~ Achieved Third Quarter 2024 Net Product Sales of $7.0 Million ~ ~ Increasing Momentum and Successful Reimbursement in the Adolescent and Young Adult (AYA) Segment Following Strategic...

07 Novembre 2024
GlobeNewswire Inc.

Fennec Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 7, 2024

RESEARCH TRIANGLE PARK, N.C., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that...

31 Octobre 2024
GlobeNewswire Inc.

Fennec Pharmaceuticals Strengthens Executive Leadership Team with Three Key Appointments to Accelerate the Company’s Next Stage of Growth

~ Pierre S. Sayad, PhD, M.S., Appointed Chief Medical Officer ~ ~ Terry Evans Appointed Chief Commercial Officer ~ ~ Christiana Cioffi, MBA, Appointed Chief Strategy Officer ~ RESEARCH TRIANGLE...

28 Octobre 2024
GlobeNewswire Inc.

Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences

RESEARCH TRIANGLE PARK, N.C., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that...

05 Septembre 2024
GlobeNewswire Inc.

Fennec Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update

~ Achieved Second Quarter 2024 Total Net Revenues of $7.3 Million ~ ~ Appointed Jeffrey S. Hackman as Chief Executive Officer (CEO) and Member of the Board of Directors ~ ~ Company Has...

13 Août 2024
GlobeNewswire Inc.

Fennec Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 13, 2024

RESEARCH TRIANGLE PARK, N.C., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that...

06 Août 2024
GlobeNewswire Inc.
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.11-1.267281105998.688.748.127008.46089714CS
41.4119.69273743027.169.16.8528868.34070448CS
121.5421.9061166437.039.15.6527826.9931282CS
26-0.55-6.030701754399.129.275.6519487.40129846CS
52-5.06-37.123991195913.6315.435.6513648.32840558CS
1563.2761.69811320755.315.435.38419.40615667CS
2600.698.756345177667.8815.434.9510139.19721759CS

FRX - Frequently Asked Questions (FAQ)

What is the current Fennec Pharmaceuticals share price?
The current share price of Fennec Pharmaceuticals is $ 8,57
How many Fennec Pharmaceuticals shares are in issue?
Fennec Pharmaceuticals has 27 027 000 shares in issue
What is the market cap of Fennec Pharmaceuticals?
The market capitalisation of Fennec Pharmaceuticals is CAD 228,65M
What is the 1 year trading range for Fennec Pharmaceuticals share price?
Fennec Pharmaceuticals has traded in the range of $ 5,65 to $ 15,43 during the past year
What is the PE ratio of Fennec Pharmaceuticals?
The price to earnings ratio of Fennec Pharmaceuticals is -14,43
What is the cash to sales ratio of Fennec Pharmaceuticals?
The cash to sales ratio of Fennec Pharmaceuticals is 10,9
What is the reporting currency for Fennec Pharmaceuticals?
Fennec Pharmaceuticals reports financial results in USD
What is the latest annual turnover for Fennec Pharmaceuticals?
The latest annual turnover of Fennec Pharmaceuticals is USD 21,25M
What is the latest annual profit for Fennec Pharmaceuticals?
The latest annual profit of Fennec Pharmaceuticals is USD -16,05M
What is the registered address of Fennec Pharmaceuticals?
The registered address for Fennec Pharmaceuticals is C/O LABARGE WEINSTEIN LLP, 515 LEGGET DRIVE, SUITE 800, OTTAWA, ONTARIO, K2K 3G4
What is the Fennec Pharmaceuticals website address?
The website address for Fennec Pharmaceuticals is www.fennecpharma.com
Which industry sector does Fennec Pharmaceuticals operate in?
Fennec Pharmaceuticals operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
APSAptose Biosciences Inc
$ 0,42
(75,00%)
30,28k
RTGRTG Mining Inc
$ 0,04
(60,00%)
3k
BNGBengal Energy Ltd
$ 0,015
(50,00%)
1 000
BBBlackBerry Limited
$ 5,29
(23,60%)
13,59M
ARAAclara Resources Inc
$ 0,495
(17,86%)
27,19k
BABYElse Nutrition Holdings Inc
$ 0,01
(-33,33%)
190k
DIAMStar Diamond Corporation
$ 0,015
(-25,00%)
2,34M
KRNKarnalyte Resources Inc
$ 0,085
(-19,05%)
20,5k
STEPSTEP Energy Services Ltd
$ 4,18
(-14,87%)
283,69k
SBISerabi Gold Plc
$ 2,13
(-11,62%)
73,81k
CNQCanadian Natural Resources Ltd
$ 42,49
(0,02%)
18,71M
TRPTC Energy Corporation
$ 65,77
(0,84%)
17,86M
CMCanadian Imperial Bank of Commerce
$ 92,48
(0,75%)
16,28M
MFCManulife Financial Corporation
$ 43,54
(0,48%)
14,47M
BBBlackBerry Limited
$ 5,29
(23,60%)
13,59M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

TSX
FRX
Fennec Pharmaceuticals
CXIO
TRXGBP
TRON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés